Anhui, China

Li Wang

This inventor holds 21 USPTO granted patents and 1 published patent application and 11 EPO patents. Top assignees: Tarapeutics Science Inc., Chinese Academy of Sciences, Precedo Pharmaceuticals Co., Ltd. Active years: 2019-2026.

USPTO Granted Patents = 21 

% Patents Active = 76.2

 

Average Co-Inventor Count = 11.7

ph-index = 1


Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: Inventor Li Wang - Revolutionizing Technology in Anhui, CN

Introduction: Li Wang is a pioneering inventor based in Anhui, China, known for her groundbreaking contributions to the field of technology. With a passion for innovation and a keen eye for detail, she has made significant strides in various technological advancements.

Latest Patents: Li Wang holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology. Her recent patents focus on sustainable solutions for environmental challenges and cutting-edge developments in the tech industry.

Career Highlights: Throughout her career, Li Wang has worked tirelessly to bridge the gap between technology and sustainability. Her innovative projects have garnered international recognition, showcasing her commitment to creating a more eco-friendly and technologically advanced world.

Collaborations: Li Wang has collaborated with leading tech companies, research institutions, and universities to further her research and bring her inventions to life. These collaborations have been instrumental in pushing the boundaries of technological innovation and driving positive change on a global scale.

Conclusion: Li Wang's dedication to innovation and sustainability has solidified her reputation as a trailblazer in the field of technology. Her inventive spirit and collaborative efforts continue to inspire the next generation of inventors and pave the way for a brighter, more sustainable future.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…